-
Tofacitinib Reverses Inflammation and Mitochondrial Dysfunct
2026-05-26
This study demonstrates that tofacitinib (CP-690550) uniquely reverses both inflammatory and metabolic defects in GM-CSF-reprogrammed macrophages from rheumatoid arthritis (RA) patients. By targeting STAT5 signaling and GM-CSFRα expression, the research highlights a mechanistically distinct approach for correcting mitochondrial and immune dysfunction, offering new directions for RA immunomodulation strategies.
-
GSH and GSSG Assay Kit: Precision in Redox State Analysis
2026-05-25
Discover how the GSH and GSSG Assay Kit enables advanced reduced glutathione detection and oxidized glutathione measurement, with a deep dive into tumor microenvironment research and practical assay optimization.
-
Chloroquine Diphosphate: Protocols and Innovations in Cancer
2026-05-25
Chloroquine diphosphate is redefining autophagy assays and therapeutic sensitization workflows in cancer research. This article delivers actionable protocol enhancements, troubleshooting strategies, and experimental context through the lens of recent mechanistic breakthroughs.
-
Mineralized Recombinant Collagen I Composite for Bone Regene
2026-05-24
This study introduces a mineralized recombinant humanized collagen type I composite, prepared using a two-step precipitation-dialysis method, to address limitations in bone grafting. The composite demonstrates biomimetic mineralization, controlled degradation, and superior support for cell proliferation and bone regeneration, offering a promising alternative for clinical bone defect repair.
-
HATU in Peptide Synthesis Chemistry: Applied Workflows & Ins
2026-05-23
HATU streamlines high-yield amide and ester formation, empowering peptide synthesis workflows to achieve rapid, reproducible results. This article bridges innovative research findings with hands-on protocol optimization, delivering actionable troubleshooting tips for maximizing efficiency and selectivity in complex synthetic tasks.
-
ATM Inhibition Promotes Macropinocytosis and Metabolic Adapt
2026-05-22
This study reveals that ATM kinase inhibition stimulates macropinocytosis, enhancing cancer cell survival in nutrient-poor environments. The findings identify a novel metabolic vulnerability induced by ATM inhibition, offering new avenues for combination cancer therapies targeting both DNA damage response and nutrient scavenging pathways.
-
TCF25 Regulates Lysosomal Adaptation and Cell Death in Gluco
2026-05-22
Ren et al. (2025) identify TCF25 as a critical nutrient sensor that orchestrates cellular adaptation and cell death during glucose starvation by enhancing lysosomal acidification and ferritinophagy. These findings reveal a novel regulatory axis with implications for metabolic and ischemic disease models.
-
Sulfo-NHS-Biotin in Single-Cell Functional Screening: New Fr
2026-05-21
Explore the advanced role of Sulfo-NHS-Biotin in high-throughput single-cell screening and cell therapy innovation. This article delves into the reagent’s mechanism, scientific advances, and unique applications, offering insights not found in standard protein labeling guides.
-
GSH and GSSG Assay Kit: Advancing Reduced Glutathione Detect
2026-05-21
The GSH and GSSG Assay Kit streamlines redox state analysis, enabling reliable quantification of reduced and oxidized glutathione in diverse biological samples. This comprehensive guide delivers actionable workflows, troubleshooting strategies, and translational insights for researchers studying oxidative stress, immunometabolism, and tumor biology.
-
HERC5-Driven IRF3 ISGylation Promotes Podocyte Injury in Lup
2026-05-20
This study uncovers a novel mechanism by which HERC5-mediated ISGylation of IRF3 stabilizes the transcription factor, leading to sustained IFN-β production and inflammatory injury in podocytes central to lupus nephritis. The findings highlight HERC5 as a potential therapeutic target for mitigating glomerular damage in autoimmune kidney disease.
-
GSH and GSSG Assay Kit: Precision Tools for Tumor Hypoxia an
2026-05-20
Explore advanced applications of the GSH and GSSG Assay Kit in reduced glutathione detection and tumor immunometabolism research. This article provides a deep dive into assay methodology, mechanistic insights, and novel guidance for redox state analysis beyond conventional approaches.
-
AP20187 in Conditional Gene Therapy: Unveiling Dimerization
2026-05-19
Explore how AP20187, a chemical inducer of dimerization, enables precision-controlled gene therapy and fusion protein regulation. Discover new insights on pathway selectivity and experimental design, grounded in recent proteomics research.
-
Gramine Induces Ferroptosis in TNBC via CUL3–MTDH Modulation
2026-05-19
The referenced study reveals that gramine, a natural indole alkaloid, selectively suppresses triple-negative breast cancer (TNBC) by inducing ferroptosis through the CUL3–MTDH ubiquitination pathway. This mechanistic insight suggests a promising direction for therapeutic intervention in aggressive breast cancer subtypes and highlights the value of targeted cell viability assays for mechanistic validation.
-
Brefeldin A: Applied ER Stress and Apoptosis Induction in Ca
2026-05-18
Brefeldin A (BFA) enables precise, reproducible induction of ER stress and apoptosis in cancer cell models, leveraging its unique blockade of ER-to-Golgi trafficking. This article details practical workflows, troubleshooting strategies, and assay innovations that maximize BFA’s utility for mechanistic and translational research.
-
Difloxacin HCl: Advancing Antimicrobial and MDR Reversal Ass
2026-05-18
Difloxacin HCl stands at the forefront of quinolone antimicrobial antibiotic research, uniquely bridging robust antimicrobial susceptibility workflows and cutting-edge multidrug resistance (MDR) reversal assays. This article delivers actionable protocols, troubleshooting expertise, and translational insights—empowering scientists to harness APExBIO's high-purity Difloxacin HCl for next-generation microbiology and oncology investigations.
387 records 6/26 page Previous Next First page 上5页 678910 下5页 Last page